MagicNurse Intelligent Blood Collection Robot

The MagicNurse Intelligent Venipuncture & Blood Collection Robot represents a breakthrough in laboratory pre-analytical automation, performing the complete blood collection workflow without human intervention. As the world’s only NMPA Class III certified autonomous blood drawing device, it addresses chronic challenges in clinical phlebotomy including needle-stick injuries, sample quality variability, and healthcare worker shortages.

Product Overview

Developed by Beijing Magicnurse Surgical Robot Technology Co., Ltd., this system automates the entire venipuncture process from patient identification through post-collection wound care. The robot uses AI-powered machine vision trained on over 200,000 vascular images to identify optimal puncture sites, achieving vein recognition rates exceeding 97% and first-stick success rates around 95%.

The device targets high-volume outpatient blood collection areas where standardization and efficiency directly impact laboratory throughput and patient experience. Clinical validation studies demonstrate specimen quality equivalent to skilled manual collection while reducing patient-reported pain levels.

Key Features

MagicNurse is the world’s first NMPA Class III certified autonomous blood collection robot, trained on over 200,000 vascular images and achieving a vein recognition rate above 97%.

• Full-chain automation: Covers tube/needle supply, tourniquet application, skin disinfection, vein identification, needle insertion, blood drawing, needle withdrawal, and wound dressing
• AI vein recognition: Machine vision system identifies blood vessels with over 97% accuracy using infrared imaging and proprietary algorithms
• Standardized collection: Reduces blood residue error to 3% compared to approximately 20% with manual collection
• Patient interaction: Integrated voice guidance and display screen provide real-time feedback during the procedure
• Infection control: Single-use consumables and automated disinfection minimize cross-contamination risks

Technical Specifications

For laboratory medicine, Beijing MagicNurse’s robot delivers a 94.3–97.14% puncture success rate while reducing blood residue error from 20% to 3% versus manual collection.

Clinical Applications

The MagicNurse robot is designed for routine venous blood specimen collection in clinical laboratories, supporting standard vacuum blood collection tubes for:

• Complete blood count (CBC) and coagulation testing
• Biochemical analysis panels
• Immunological assays
• Routine health screening programs

The system is particularly suited for patients who experience needle anxiety or vasovagal responses during blood collection. Studies at Zhongshan Hospital found that 90 of 154 volunteers reported lower pain perception with robotic collection compared to manual methods.

Limitations

Current contraindications include:

• Patients under 18 years of age (standard model)
• Patients with coagulation disorders
• Arm or vascular anatomical abnormalities
• Significant tattoos or scarring obscuring vein visibility
• Patients requiring collection from non-standard sites

Regulatory Status

MagicNurse obtained NMPA Class III medical device registration in 2019 and received ISO 13485 quality management system certification in December 2020. The device represents the world’s first and currently only commercially approved autonomous venipuncture robot.

Clinical Evidence

A prospective study published in Frontiers in Medicine (2023) evaluated the MagicNurse system at Zhongshan Hospital, Fudan University, comparing robotic and manual collection in 154 volunteers. Key findings:

• Puncture success rate: 94.3% for robotic collection
• Specimen quality: No clinically significant differences in 11 anticoagulant blood parameters
• Patient preference: 70% (108/154) willing to use robotic collection again
• Pain perception: 58% (90/154) reported lower pain with robotic collection

A deployment at the First Hospital of Anhui Medical University utilizing 3 MagicNurse units successfully completed blood collection for over 5,100 patients between late 2023 and May 2024.

Frequently Asked Questions

How long does robotic blood collection take compared to manual?

The automated process currently takes slightly longer than skilled manual collection due to the systematic approach to vein identification and positioning. However, the standardized workflow reduces sample rejection rates and rework, improving overall laboratory efficiency.

Does the robot cause more or less pain than manual blood drawing?

Clinical studies indicate most patients perceive less pain with robotic collection. In the Zhongshan Hospital trial, 58% of participants reported lower pain levels with the robot compared to manual collection, attributed to the consistent, controlled needle insertion technique.

Can the MagicNurse robot be used for pediatric patients?

The current system is validated for patients aged 18 and above, with the latest generation extending coverage to patients over 80 years old. Pediatric applications would require separate clinical validation and regulatory approval.